| Harold Ray Pritchett Iii, MD | |
|
225 E Washington Ave, Jonesboro, AR 72401-3111 | |
| (870) 207-4100 | |
| Not Available |
| Full Name | Harold Ray Pritchett Iii |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Location | 225 E Washington Ave, Jonesboro, Arkansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023646734 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | E-15911 (Arkansas) | Primary |
| Entity Name | St Bernards Hospital Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396053096 PECOS PAC ID: 0941105480 Enrollment ID: O20101123000105 |
News Archive
Partial knee replacement surgery is safer than total knee replacement, according to a new study published in The Lancet today (July 8).
The goal of most cancers is to grow and take over the host's body. The immune system has long been in the crosshairs of cancer researchers, as it plays a central role in defending the human body from foreign invasion.
Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company and wholly-owned subsidiary of Sosei Group Corporation, is pleased to announce that it has entered into a licensing agreement with AstraZeneca under which AstraZeneca will acquire exclusive global rights to develop, manufacture and commercialise the adenosine A2A receptor antagonist, HTL-1071, a small molecule immuno-oncology candidate, and potential additional A2A receptor-blocking compounds.
Researcher Daniela Salvemini, Ph.D., professor of pharmacology and physiology at Saint Louis University, has been named a Fellow of the National Academy of Inventors for her contributions toward understanding and finding better treatments for pain.
› Verified 2 days ago
| Entity Name | St Bernards Physician Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447923438 PECOS PAC ID: 7012311269 Enrollment ID: O20210810001875 |
News Archive
Partial knee replacement surgery is safer than total knee replacement, according to a new study published in The Lancet today (July 8).
The goal of most cancers is to grow and take over the host's body. The immune system has long been in the crosshairs of cancer researchers, as it plays a central role in defending the human body from foreign invasion.
Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company and wholly-owned subsidiary of Sosei Group Corporation, is pleased to announce that it has entered into a licensing agreement with AstraZeneca under which AstraZeneca will acquire exclusive global rights to develop, manufacture and commercialise the adenosine A2A receptor antagonist, HTL-1071, a small molecule immuno-oncology candidate, and potential additional A2A receptor-blocking compounds.
Researcher Daniela Salvemini, Ph.D., professor of pharmacology and physiology at Saint Louis University, has been named a Fellow of the National Academy of Inventors for her contributions toward understanding and finding better treatments for pain.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Harold Ray Pritchett Iii, MD 225 E Washington Ave, Jonesboro, AR 72401-3111 Ph: (870) 207-4100 | Harold Ray Pritchett Iii, MD 225 E Washington Ave, Jonesboro, AR 72401-3111 Ph: (870) 207-4100 |
News Archive
Partial knee replacement surgery is safer than total knee replacement, according to a new study published in The Lancet today (July 8).
The goal of most cancers is to grow and take over the host's body. The immune system has long been in the crosshairs of cancer researchers, as it plays a central role in defending the human body from foreign invasion.
Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company and wholly-owned subsidiary of Sosei Group Corporation, is pleased to announce that it has entered into a licensing agreement with AstraZeneca under which AstraZeneca will acquire exclusive global rights to develop, manufacture and commercialise the adenosine A2A receptor antagonist, HTL-1071, a small molecule immuno-oncology candidate, and potential additional A2A receptor-blocking compounds.
Researcher Daniela Salvemini, Ph.D., professor of pharmacology and physiology at Saint Louis University, has been named a Fellow of the National Academy of Inventors for her contributions toward understanding and finding better treatments for pain.
› Verified 2 days ago
Dr. Matthew A. Quick, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4800 E Johnson Ave, Jonesboro, AR 72401 Phone: 870-936-8000 Fax: 870-936-1098 | |
Brock F Harris, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4800 E Johnson Ave, Jonesboro, AR 72401 Phone: 870-936-8000 Fax: 870-936-2038 | |
Dr. Abhijit Shivkumar, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 225 E Jackson, St Bernards Medical Center, Jonesboro, AR 72401 Phone: 501-681-4841 | |
Xiaolong Liu, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 225 E Jackson Ave, Jonesboro, AR 72401 Phone: 870-207-7300 | |
Hongjiang Chen, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 225 E Jackson Ave, Jonesboro, AR 72401 Phone: 870-275-8861 | |
Robert B White, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4800 E Johnson Ave, Jonesboro, AR 72401 Phone: 870-936-8000 Fax: 870-936-2038 |